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Philippe Hartemann2,5 and Philippe Grandjean6,7
Abstract
Background: Evidence of a dose–response relationship between prenatal exposure to methylmercury (MeHg) and
neurodevelopmental consequences in terms of IQ reduction, makes it possible to evaluate the economic
consequences of MeHg exposures.
Objective: To perform an economic evaluation of annual national benefits of reduction of the prenatal MeHg
exposure in France.
Methods: We used data on hair-Hg concentrations in French women of childbearing age (18–45 years) from a
national sample of 126 women and from two studies conducted in coastal regions (n = 161and n= 503). A linear
dose response function with a slope of 0.465 IQ point reduction per μg/g increase in hair-Hg concentration was
used, along with a log transformation of the exposure scale, where a doubling of exposure was associated with a
loss of 1.5 IQ points. The costs calculations utilized an updated estimate of €2008 17,363 per IQ point decrement,
with three hypothetical exposure cut-off points (hair-Hg of 0.58, 1.0, and 2.5 μg/g).
Results: Because of higher exposure levels of women in coastal communities, the annual economic impacts based
on these data were greater than those using the national data, i.e. € 1.62 billion (national), and € 3.02 billion and €
2.51 billion (regional), respectively, with the linear model, and € 5.46 billion (national), and € 9.13 billion and € 8.17
billion (regional), with the log model, for exposures above 0.58 μg/g.
Conclusions: These results emphasize that efforts to reduce MeHg exposures would have high social benefits by
preventing the serious and lifelong consequences of neurodevelopmental deficits in children.
Keywords: Economic evaluation, Methylmercury, Prenatal exposure, Neurodevelopmental deficits
Background
Human exposure to methylmercury (MeHg) occurs pri-
marily through ingestion of seafood and freshwater fish
[1]. Due to biomagnification in food chains, relatively
high MeHg concentrations occur in piscivorous marine
species [2] and may exceed the highest recommended
limit [3], while smaller non-predatory species, such as
herring or sardine, contain concentrations of one-tenth
of this limit or even less [3]. Methylation, bioaccumula-
tion through food chains, and human intake levels are
difficult to model [1]. Thus, risk assessment must rely
on biomarkers of total human uptakes.
Once absorbed, MeHg acts as a developmental neurotox-
icant [4-7]. As the critical effect is considered to be develop-
mental brain toxicity [8,9], MeHg intake by pregnant
women is of primary concern [10]. In the 1990s, results
emerged from three large epidemiologic studies in New
Zealand, the Faroe Islands and the Seychelles Islands [6,11-
14]. The first two concluded that chronic low-dose prenatal
MeHg exposure from maternal consumption of fish was
associated with subtle end points of neurotoxicity in chil-
dren [15]. Support for the notion of seafood-mediated
MeHg neurotoxicity later emerged also from the Seychelles
[16]. In further research, Faroes investigators provided
extended evidence of a dose–response relationship between
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prenatal MeHg exposure and lasting neurodevelopmental
deficits [15,17,18]. Subsequently, epidemiological studies in
French Guiana [19-21] and in other parts of the world [22-
24] showed the effects of MeHg on childhood neurodeve-
lopmental disorders. This research has prompted further
studies focused on French populations, especially in coastal
regions of western France [3,25].
Reducing human exposure to anthropogenic mercury
is both a public health priority and an economic chal-
lenge, and controversies persist in both research inter-
pretation and policy decisions [10]. The consequences
of MeHg contamination, similar to those observed for
lead (Pb) exposure in children, include a loss in
Intelligence Quotient (IQ), with associated lower
school performance and educational attainment, thus
leading to long-term impacts on societal benefits of
pollution abatement [26,27]. The economic impacts
caused by MeHg on humans have been assessed in the
United States, through the studies by Rice et al.
[28,29] and publications from the US Environmental
Protection Agency (EPA) [30], and the study of Grif-
fiths et al. [31]. Although these calculations have been
extrapolated to global estimates [32,33], few economic
evaluations have been performed in Europe [34,35]. To
extend and update the international assessments of
economic impacts of MeHg exposure and to utilize
biomonitoring data, the present study aims to assess
the economic consequences of MeHg-associated neuro-
toxicity, using exposure data from French studies. As
biomonitoring results become available from other
countries, additional national estimates can be made
using the same methodology.
The economic assessment requires toxicological and
epidemiological assumptions. Hg concentrations in hair
and in umbilical cord blood have been used as biomar-
kers to ascertain prenatal exposure to MeHg, although
both exposure indicators are associated with some im-
precision[36]. In selecting the dose–response function
(DRF), a major difficulty arises when deciding on the
MeHg dose metric [15]. While a linear model is at-
tractive, it does not provide the best statistical fit to
the data [18]. Studies that used a log transformed ex-
posure scale assume that each doubling of exposure
causes the same deficit. In the absence of a clear
threshold, an additional decision has to be made in re-
gard to a toxicological reference value, so that the epi-
demiological findings are translated into a “cut-off
point”, below which only negligible adverse effects
exist. Using both a linear and a logarithmic dose–re-
sponse curve (DRC), we provide estimates of the eco-
nomic consequences of prenatal MeHg exposure for
three different such cut-off points as a basis for devel-
opment of public policies to prevent MeHg exposure
at national and international levels.
Methods
Data sources
Three samplings of maternal hair
The first source of data is the 2006–2007 French national
survey on nutrition and health ENNS (Etude Nationale
Nutrition Santé) run by the French Institute for Public
Health Surveillance (InVS). We used a national sub-
sample of 18–45 year old women (n =126) representing
the population of childbearing age. The geometric mean
of hair-Hg concentrations was 0.53 μg/g (interquartile
range 0.37-0.82 μg/g; full range 0.073-5.1 μg/g) [37].
The second source of data is the regional 2002–2006
PELAGIE cohort study from Brittany, the most western
region of France, partly surrounded by the Atlantic
Ocean, carried out by the National Institute of Health
and Medical Research (INSERM U1085) to explore the
role of environmental pollutants on pregnancy and de-
livery outcomes, and on children’s health and develop-
ment [25]. The PELAGIE cohort includes 3421 pregnant
women enrolled in early pregnancy by medical practi-
tioners in three districts of Brittany. A sub-cohort of 601
women was randomly selected for biomarker determin-
ation, including mercury from 503 (84%) maternal hair
samples collected at delivery. The geometric mean of
hair Hg concentrations was 0.62 μg/g (interquartile
range 0.40-0.94 μg/g; full range 0.06-3.42 μg/g).
The third source of data is a 2005–2006 study from the
National Institute of Agricultural Research (INRA) [3]. In
this study, hair Hg levels were clustered in relation to fish
consumption of pregnant women admitted in three hospi-
tals in the Loire-Atlantique coastal district. Two hospitals
were located in Nantes, the regional capital, and its sub-
urb, and one in Saint-Nazaire. The frequency of fish con-
sumption is higher in this region than in other French
regions more distant from the ocean [38]. Fish consump-
tion and hair mercury concentrations were assessed dur-
ing two visits at 12 and 32 weeks of pregnancy (n =161 for
the first visit; n =137 for the second). The more complete
first sample showed a geometric mean hair-Hg concentra-
tion of 0.67 μg/g (interquartile range 0.42-0.94 μg/g; full
range 0.00-3.66 μg/g).
Reference values for hair-mercury and conversion into cord
blood concentrations
Different toxicological reference values for neurotoxicity
have been recommended for setting exposure limits.
Thus, the Joint FAO/WHO Expert Committee on Food
Additives (JECFA) recommends MeHg doses not to ex-
ceed 0.23 μg/kg body weight per day (bw/day), corre-
sponding to 2.5 μg/g hair, above which there may be a
risk for children, especially through exposure of preg-
nant or lactating women [39]. The U.S. EPA developed a
MeHg Reference Dose (RfD) which is 0.1 μg/kg bw/day,
corresponding to 1 μg/g hair [1]. We also considered a
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third value based on updated findings from the pro-
spective studies in the Faroes [36], which resulted in an
exposure limit about 50% below the level recommended
by the U.S. National Research Council (NRC), corre-
sponding to 0.58 μg/g hair, the lowest of the three refer-
ence values. Below, these three values will be used as
three hypothetical cut-off points. MeHg exposures at
these levels are considered to be negligible and accept-
able, but they do not necessarily represent a level at
which there is no effect on neurodevelopment [15].
The dose–response function for IQ losses
Several possible linear and logarithmic dose–response
models have been proposed to represent the relationship
between Hg exposure and the neurodevelopmental out-
comes. Based on the Faroe Islands data, the NRC recom-
mended a linear dose–response model [15]. The Faroes’
investigators showed that a logarithmic model provided
a better fit to the data than the linear one, although the
difference between the two was barely statistically sig-
nificant [18]. Accordingly, we used both the linear DRF
model, and the log DRF model.
For the linear model, a 1 μg/L increase of the cord
blood Hg concentration is associated with an average ad-
verse impact on IQ of 0.093 IQ point of the standard de-
viation (SD), which is 15, thus estimated at 0.465 IQ
points [40], assuming that the ratio between mercury in
hair and in cord blood is 200. These values derive from
the Budtz-Jørgensen report [18] and pertain to a range
of neuropsychological tests and subtests administered in
the Faroe Islands study when the children were assessed
at age 7 years, including IQ subtests.
Hence, assuming a linear DRF and a central estimate
of the slope of 0.465 IQ points per μg/g hair increase,
we computed IQ decrements above the three hypothet-
ical cut-off points defined above. Losses of IQ were esti-
mated for the following concentration ranges: [0.58 μg/g
– 1.0 μg/g], [1.0 μg/g −2.5 μg/g] and ≥2.5 μg/g, based on
y0 ¼ 0:465 xþ b ð1Þ
Where y’ denotes the change in IQ point and x is the
hair-Hg concentration, and b the intercept specific for
each cut-off point. Thus, y’ equals 0 at each hypothesized
cut-off point:
y00:58μg=g ¼ 0:465x 0:27 ð2Þ
y01μg=g ¼ 0:465x 0:465 ð3Þ
y02:5μg=g ¼ 0:465 x 1:162 ð4Þ
We assumed a stable diet of infants and mothers, so
that any detailed time distribution of the sensitivity to
Hg does not matter for the calculation of impacts [32].
Consequently, we considered that the DRF slope (0.465
IQ points per μg/g hair) in equation (1) represents the
lifetime neurodevelopmental impairment experienced by
a child whose mother has been exposed to a continuous
Hg dose indicated by the hair-Hg concentration (HHg)
measured. Thus, the lifetime impact on a child exposed
above the three selected cut-off points, was estimated
according to equations (2), (3) and (4) (Figure 1). In the
linear model, we selected the median of each of the low-
est intervals [0.58-1 μg/g], [1–2.5 μg/g] to represent all
subjects within the interval, i.e. 0.79 μg/g and 1.75 μg/g.
For the national sample, 2.62 μg/g was considered to
represent all subjects with results above 2.5 μg/g based
on the Percentile P99.5, while excluding the extreme
value (2.74 μg/g). Similarly, the mid-points for the high-
est exposure group were 2.76 μg/g for the Brittany sam-
ple and 3.08 μg/g for the Loire Atlantique sample.
For the log model, the Faroes data suggested that the
most sensitive brain functions showed a delay in devel-
opment of 1.5–2 months at age 7 years associated with
each doubling of the prenatal MeHg exposure. This
delay corresponded to about 10% of the SD for these
tests, which would correspond to about 1.5 IQ points
[41]. So the equation for IQ loss above the lowest cut-off
point is the following:
IQ ¼ IQbaseline α∗ log2 HHg=0:58ð Þð ð5Þ
Where IQ baseline is the IQ with 100 points, α is 1.5 IQ
points, HHg is the hair–Hg concentration (log2 trans-
formed), and 0.58 (μg/g) the cut-off point (see Figure 1).
Figure 1 Loss of IQ points according to HHg concentrations
based on linear and log models. Figure 1 displays the comparison
of IQ decrements associated with HHg concentrations based on a
linear model in red lines and a logarithm model in blue lines. In the
first, estimates of IQ point loss are presented for the three cut–off
points 0.58, 1.0 and 2.5 μg/g and for the maximum (i.e. the
Percentile P99.5, extreme value excluded) for the three samples. In
the log model, IQ point losses are given above 0.58 μg/g. And, we
assumed no IQ loss below the three cut-off points.
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For the interval [0.58-1 μg/g], the mid-point on the
log scale is chosen as the representative exposure for all
subjects within this interval. The mid-point is 0.76 [anti-
log (−0.12)], which corresponds to an increase of HHg
by 31% above the 0.58 μg/g cut-off. As a doubling would
result in an IQ loss of 1.5 points, the increase by 31%
corresponds to an IQ loss of slightly more than 0.5
points. This is used as the average IQ loss for all subjects
within this interval. For the interval [1–2.5 μg/g], the
value of 1.16 is chosen as representative for the subjects
within this interval due to the skewed distribution of
HHg with most subjects much closer to 1 than to
2.5 μg/g. The value of 1.16 corresponds to a doubling of
the 1 cut-off level, thus to an average IQ loss of 1.5
points. Similarly, subjects above the 2.5 cut-off were
assigned an average of 2.9 μg/g, i.e. 5 times the cut-off
or 2.32 doublings, which correspond to a loss of
1.5*2.32 = 3.5 points.
Annual benefits of exposure reduction
As explained above, the effects of prenatal MeHg tox-
icity on children can be considered to be similar to those
of developmental lead exposure. Both exposures are
associated with a reduced IQ, which in turn has a nega-
tive impact on the social benefits. According to an im-
pact evaluation applied to childhood lead exposure [26],
the major component of the social costs incurred by an
IQ reduction is loss of productivity and thus a lower
earning potential. In the present study, the economic
consequence of MeHg prenatal exposure is assessed for
a birth cohort of children born to women of childbear-
ing age (18–45 years) and valued as the lifetime earning
loss per person and extrapolated to the French national
birth cohort of 834,000 children born in 2008 [42]. That
year was found to be the closest to the time during
which the exposure data had been collected. We
assumed singleton births only, so that the number of
women was equal to the cohort size.
Health impact: MeHg lifetime impact on the exposed
population
In the national sample, the Brittany study and the Loire
Atlantique study, respectively, the exposure levels were
based on the percentage of women with hair Hg concen-
trations within the 0.58 μg/g - 1 μg/g, 1 μg/L - 2.5 μg/g
and ≥2.5 μg/g ranges. For the three studies, these were
43.8%, 14.5%. and 0.6% (national); 55%, 33%, and 1.2%
(Brittany); and 60%, 22.5%, and 1.9% (Loire Atlantique).
Lastly, we applied those percentages to the 2008 cohort
assuming the three sample distributions measured the life-
time impacts, i.e. the effects of MeHg in terms of IQ
points permanently lost. Although some compensation
may be possible over time, current evidence suggests that
MeHg-linked cognitive deficits are lasting [17].
Irrespective of future exposure reductions a child whose
IQ has been impaired due to early life exposure will never
recover from a retardation that is irreversible.
Economic impact: Benefits of reduction of the MeHg
exposure
The estimated individual benefits are the avoided life-
time costs. They originate from the figure of €200817,
363 per IQ point loss that we published recently for Pb
intoxication [26], the most recent value available. We
computed the MeHg-related avoided cost for an IQ
point decrement for an individual i, denoted Bi, as fol-
lows:
Bi ¼ NIQi  €17; 363 ð6Þ
Where NIQi is the number of IQ points loss for subject
i.
The population benefits of reducing mercury exposure
were estimated within the three concentration ranges:
[0.58- 1], [1–2.5] and ≥2.5 μg/g denoted B[range], as fol-
lows:
B range½  ¼
X
i
Bi ð7Þ
where
X
i
denotes the sum of all individual benefits
within a given exposure range.
Lastly, the total population benefits (TB) are cumula-
tive, thus being the sum of the Brange values within each
segment of the corresponding distribution: denoted
TB0.58, TB1 and TB2.5, respectively, according to the fol-
lowing equations:
TB0:58 ¼ B 0:581½  þ B 12:5½  þ B 2:5max½  ð8Þ
TB1 ¼ B 12:5½  þ B 2:5max½  ð9Þ
TB2:5 ¼ B 2:5max½  ð10Þ
The estimated benefits Bi, B[range] and TB based on lost
earnings are valuated at their present value since they
correspond to current exposure.
Results
As shown in Table 1, the three study populations exhibit
different exposure distributions. While the exposure
levels are the lowest in the national sample, the distribu-
tion is shifted towards higher values in Brittany and,
even more so, in Loire Atlantique. Associations between
IQ losses and HHg exposures assuming linear and loga-
rithmic relationships are reported for the different distri-
butions and scenarios in Figure 1.
Table 2 and Table 3 present the IQ losses and the esti-
mates of the economic impact for the linear model,
expressed as benefits associated with Hg exposures above
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the three cut-off points for the 2008 birth cohort assuming
exposure distributions based on the three study samples.
Due to the differences in exposure, the greatest benefits
would be achieved with the Brittany sample, should all
values be reduced below 0.58 μg/g. The estimated median
annual total benefits were € 1.62 billion, € 0.77 billion, and
€ 0.005 billion using the national sample, according to the
three cut-off points (0.58, 1.0, and 2.5 μg/g). The corre-
sponding values were € 3.02 billion, € 1.75 billion € and €
0.02 billion using the Brittany data, and € 2.51 billion, €
1.31 billion and € 0.07 billion from the Loire-Atlantique
exposure distribution. If we had used a rounded cut-off
level of exposure at 0.5 μg/g , the total benefits estimated
for the national sample would have been about 17% higher
than those estimated to be above the cut-off level of
0.58 μg/g.
Table 4 presents the benefits associated with different
levels of Hg exposure reductions by using the logarithm
model. For all three samples, we used the same number
of children per range for the both models (Table 1). The
estimated total benefits were € 5.46 billion, € 9.13 bil-
lion, and € 8.17 billion based on the national, Brittany
and Loire-Atlantique exposure distributions, respect-
ively, above the 0.58 μg/g cut-off. Thus, the total benefits
were estimated to be more than three times higher than
those obtained from the linear model (Figure 2).
Discussion
The aim of this article was to evaluate the economic
impacts of neurotoxicity associated with prenatal MeHg
exposure in France. Our estimations were carried out as-
suming a linear and a logarithmic relationship between
Hg exposure and IQ losses [6,18], for three hypothetical
cut-off points, 0.58 μg/g, 1.0 μg/g and 2.5 μg/g, respect-
ively, based on three different evaluations [1], [36] and
[39]. In agreement with European [43] recommenda-
tions, we do not pretend that any of the cut-off points
are completely safe exposure levels, but merely represent
hypothetical exposure levels below which adverse effects
might be negligible. Three French data sets, i.e., national,
Table 1 Number of children from the 2008 birth cohort exposed to different levels of MeHg based on HHg
concentrations in three French population samples
Distributions HHg concentration ranges (μg/g) Number of children (N) (%)
National Hg< 0.58 126,101 26
0.58≤Hg< 1.0 244,529 50
1.0≤Hg< 2.5 115,926 24
Hg≥ 2.5 5,087 1
All 491,643 100.00
Brittany Hg< 0.58 285,228 38
0.58≤Hg< 1.0 183,480 25
1.0≤Hg< 2.5 265,212 36
Hg≥ 2.5 10,008 1
All 743,928 100.00
LA Hg< 0.58 203,496 29
0.58≤Hg< 1.0 312,750 44
1.0≤Hg< 2.5 171,804 24
Hg≥ 2.5 15,846 2
All 703,896 100.00
The Table 1 presents the number of children from the 2008 birth cohort exposed to different levels of MeHg based on HHg concentrations in three French
population samples. We noted that 58.95% of women of childbearing age corresponded to the national sample, 89% to the Brittany and 84% to the LA sample,
respectively.
Table 2 Estimated IQ losses for the selected HHg cut-off points range in the three samples with the linear model
National sample Brittany sample Loire Atlantique sample
HHg concentrations
ranges (μg/g)
[0.58;1.00] [1.00;2.50] [2.50;2.74] [0.58;1.00] [1.00;2.50] [2.50;3.02] [0.58;1.00] [1.00;2.50] [2.50;3.66]
Loss of IQ point From 0.58 0.20 0.89 1.00 0.20 0.89 1.13 0.20 0.89 1.43
From 1.00 0.70 0.81 0.70 0.94 0.70 1.24
From 2.50 0.11 0.24 0.54
The Table 2 presents the IQ losses, for the linear model, the upper bound value per segment from the three cut-off points (0.58, 1.0 and 2.5 μg/g) for the 2008
birth cohort assuming exposure distributions based on the three study samples.
Pichery et al. Environmental Health 2012, 11:53 Page 5 of 10
http://www.ehjournal.net/content/11/1/53
Brittany and Loire Atlantique, enabled a characterization
of the Hg exposure distribution from exposure bio-
marker results in women of childbearing age or pregnant
women. Data were applied to the 2008 national birth co-
hort. We calculated the health impact (loss of IQ/indi-
vidual) and the annual economic impact or benefits of
Hg reduction in terms of personal avoided costs and for
the entire cohort (Bi and TB, respectively), above each
cut-off point.
These results highlight that prenatal MeHg exposure
has serious impacts on the life-time productivity and on
society due to adverse cognitive and associated eco-
nomic consequences. Benefits were higher with the loga-
rithmic than the linear model (see Figure 2), as the
logarithmic DRF is steeper at low exposure levels that
affect a larger proportion of children. The two regional
exposure estimates, close to sea coasts, where marine
food is more easily available, are higher than the national
ones. This finding is in line with the French national sta-
tistics for fish consumption, which show that the popu-
lation residing on the western coast of France (18% of
the total population) consumes more of the total
amount of fish available in the whole country for numer-
ous species [38,44].
The results show that policies that aim to reduce
childhood MeHg exposure would have large-scale social
benefits. The focus on a child’s life-time earning loss is
similar to the avoidable costs in relation to lead expos-
ure reduction [26]. Other costs were ignored, such as
direct medical costs linked to treatment or interventions
Table 3 Estimated lifetime economic benefits of reducing MeHg exposure in the 2008 children’s cohort according to
the three study samples with the linear model
National sample Brittany sample Loire Atlantique sample
HHg concentrations
ranges (μg/g)
[0.58;1.00] [1.00;2.50] [2.50;2.74] [0.58;1.00] [1.00;2.50] [2.50;3.02] [0.58;1.00] [1.00;2.50] [2.50;3.66]
Bi
(€/individual)
From
0.58
[0.00;3,473] [3,473;15,453] [15,453;17,439] [0.00;3,473] [3,473;15,453] [15,453;19,668] [0.00;3,473] [3,473;15,453] [15,453;24,829]
From
1.00
[0.00;12,154] [12,154;14,048] [0.00;12,154] [12,154;16,277] [0.00;12,154] [12,154;21,509]
From
2.50
[0.00;1,938] [0.00;4.166] [0.00;9,398]
B[range]
(€ billion)
(midpoint
value)
From
0.58
0.45 1.09 0.08 0.33 2.51 0.18 0.56 1.63 0.32
From
1.00
0.70 0.07 1.61 0.14 1.04 0.27
From
2.50
0.005 0.02 0.07
TB
(€ billion)
(midpoint value)
From 0.58 From 1.00 From 2.50 From 0.58 From 1.00 From 2.50 From 0.58 From 1.00 From 2.50
1.62
[0.5;2.73]
0.77
[0.06;1.48]
0.005
[0.00;0.0098 ]
3.02
[1.08;4.93 ]
1.75
[0.12;3.39 ]
0.02
[0.00;0.042 ]
2.51
[0.84;4.13 ]
1.31
[0.19;2.43 ]
0.07
[0.00;0.15]
Table 3 presents the estimates of the economic impact for the linear model, expressed as individual benefits (Bi), benefits per range (B[range]) and the total
benefits for one year (TB), associated with Hg exposures from the three cut-off points for the 2008 birth cohort assuming exposure distributions based on the
three study samples.
Table 4 Estimated lifetime economic benefits to reducing MeHg exposure in the 2008 children’s cohort according to
the three study samples with the log model
National sample Brittany sample Loire Atlantique sample
HHg concentrations
ranges (μg/g)
[0.58;1.16] [1.16;2.90] [2.90;.Max ] [0.58;1.16] [1.16;2.90] [2.90;.Max ] [0.58;1.16] [1.16;2.90] [2.90;.Max ]
Bi (from 0.58)
(€/individual)
8682 26134 60771 8682 26134 60771 8682 26134 60771
B[range[
(from 0.58)
(€ billion)
2.12 3.03 0.31 1.59 6.93 0.61 2.72 4.49 0.96
TB (from 0.58)
(€ billion)
5.46 9.13 8.17
Table 4 presents the estimates of the economic impact for the logarithm model, expressed as individual benefits (Bi), benefits per range (B[range]) and the total
benefits for one year (TB), associated with Hg exposures from 0.58 μg/g for the 2008 birth cohort assuming exposure distributions based on the three study
samples. Losses of IQ are 0.5, 1.5 and 3.5 IQ points for [0.58; 1.16], [1.16; 2.90] and [2.90; Max], respectively.
Pichery et al. Environmental Health 2012, 11:53 Page 6 of 10
http://www.ehjournal.net/content/11/1/53
for children with neurodevelopmental disorders. We also
neglected indirect costs, such as those related to special
education or additional years of schooling for children
as a consequence of these disorders, as well as intangible
costs. In addition, our study did not consider other
avoided direct health care costs, such as those poten-
tially related to the treatment of cardiovascular or neu-
rodegenerative effects of MeHg exposure, which could
be important for high fish consumers [5], but would be
difficult to estimate.
Several uncertainties hamper accurate impact estima-
tion. One concerns the slope of the dose–response rela-
tionship between maternal MeHg exposure and loss of
IQ points. Our first estimates used an average mean of
0.465 IQ point loss per μg/g in HHg. The lower bound-
ary (0.295 IQ point loss per μg/g) or the upper one (0.62
IQ point loss per μg/g) can be also used to obtain min-
imal or conservative estimates. We used both the linear
and the log DRF, as the latter scale showed a better fit,
suggesting that a doubling of exposure is associated with
a loss of 1.5 IQ points [41]. This slope is of course also
uncertain.
Three large-scale prospective epidemiologic studies
investigated children who experienced MeHg exposures
in utero at concentrations relevant: the Faroes study [6],
the New Zealand study [11,12], and the Seychelles study
[13,14]. These studies provided evidence of a dose–re-
sponse relationship between concentrations of MeHg
and neuro-developmental disorders among children [9].
As also decided by the NRC [15], we relied on the Far-
oes study as the most extensive data base that was only
minimally affected by confounding. This way, we
avoided considerations of residual confounding from
seafood benefits. Also, in regard to the three cut-off
points, recent research [22,24] reflects the occurrence of
adverse effects close to the lowest cut-off level. However,
it is unclear when effects become negligible, and this un-
certainty in particular affects the estimates based on the
log curve.
While the use of biomonitoring data from random
samples of the general population is an advantage, our
calculations were based on sample sizes ranging between
126 and 503 at national and regional levels. The repre-
sentativeness of the study samples can be challenged,
and larger surveys are needed to obtain more precise
data, especially in regard to the prevalence of high-level
exposures.
Comparison of mean mercury exposure distributions
in different countries indicates that, France exhibits Hg
concentrations that are greater than in Germany and the
US. The consumption of fish in the latter countries is
about half that of the French, while countries such as
Spain, Sweden and Japan show greater consumption fig-
ures [37]. Our results, in line with US findings [33,34],
document that a reduction of childhood MeHg exposure
may have substantial social benefits. The monetary value
of the annual health benefits due to prevention of cogni-
tive disorders generated by a 20% reduction exposure to
MeHg in the US population was estimated at $US 170
million/year [29], but this result was certainly underesti-
mated due to underestimation of the hair mercury-IQ
dose response slope and the high threshold for neuro-
toxicity. Using a different approach, Trasande et al. cal-
culated that decreased economic productivity resulting
from diminished intelligence over a lifetime results in an
aggregate economic cost in each annual birth cohort of
$US 8.7 billion annually (range: $0.7–$13.9 billion, $2000)
[40]. About 15% of this cost was said to be attributable
to mercury emitted from coal-fired power plants in the
United States [40], although the basis for these calcula-
tions may be challenged. In comparing these figures to
the ones calculated for France, note should be taken that
annual US birth cohorts are about five times greater.
Despite the differences in assumptions and published
estimates, the results document that benefits of MeHg
exposure control are substantial.
Our paper did not estimate the annual costs of invest-
ments in pollution abatement because of the paucity of
the available data. The known investment costs for Hg
emissions control include data from reduction of mer-
cury usage in the chlorine industry (estimation of €2005
0.4 billion), measures taken in dentistry (€1997 0.031 bil-
lion), plus expenses for recycling and treatment of mer-
cury releases. These French expenses are total, not
annualized. While the utility industry is responsible for a
main part of global mercury emissions, its contribution
and the costs for abatement vary substantially between
countries. In the US, an estimate of $US750 million per
year has been reported for industrial investments needed
to obtain a reduction of Hg emissions [35]. However,
abatement efforts should not be undertaken at a national
level alone, and calculations need to consider global
expenses. Thus, due to regional and hemispherical air
Figure 2 Estimated annual benefits from MeHg reduction
exposure above 0.58 μg/g, in the 2008 children cohort (in €
2008 Billion).
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dispersion of Hg, a concerted European policy on the
emissions is necessary to obtain significant reductions of
exposure levels in Europe. The French Institute for In-
dustrial Risks (INERIS) has put forward two main routes
for the reduction of mercury releases in the environ-
ment: one is substitution of mercury by non-fossils fuels
(wood, biogas, biomass) in oil or coal combustion plants
and by process changes in the chlorine industry (change
to the membrane cell technology); the second would en-
courage more effective ways to collect and recycle waste
containing mercury in batteries, thermometers, dental
amalgams, and energy-saving lamps [45]. These costs
would have additional socio-economic yields from better
control of mercury emissions: job creation and
modernization of capital equipment [46].
Methylmercury exposure mainly originates from fish
and seafood, which contain essential nutrients that have
beneficial effects on brain development [8], [47]. For this
reason, a reduction in the concentrations of MeHg in
fish is a desirable long-term goal rather than a replace-
ment of fish in the diet by other foods. In the interim,
the best method of maintaining fish consumption and
minimizing Hg exposure is the consumption of fish
known to have lower MeHg concentrations [15] and
advisories to women about avoiding Hg intake during
pregnancy and breastfeeding may be a cost-effective pre-
ventive action.
French studies and recommendations from the French
Agency for Food, environmental and Occupational
Health Safety (ANSES), stress the need for health educa-
tion regarding fish species consumption in order to pro-
tect vulnerable populations. The INRA study provided
evidence on the risks and the benefits of fish consump-
tion by pregnant women to guide decision making in
order to reduce risks and optimize nutritional benefits in
consumers [3,44]. Thus, implementation of consumption
strategies within populations at risk can be in the form
of pertinent dietary recommendations [48].
Other factors also play a role in regard to fish con-
sumption. The Sustainable Development indicators show
that, despite the implementation of quotas, overfishing
continues: 13% of so-called pelagic fish catches (includ-
ing tuna) are in excess to the precautionary threshold
[49] and may for this reason need to be diminished. In
this connection, economic aspects of the fishing industry
can also be considered. While tuna is high in MeHg
content, it is the most popular of seafood species con-
sumed in France (220,000 tons/y between 2008 and
2010) [56, 57], mainly canned (about 94% of the value of
household purchases of tuna), and represents 8-9% of
household expenditures for fish purchases, i.e. € 0.56 bil-
lion in 2010. For comparison, sardines are cheaper and
with low MeHg but consumed less frequently (63,000
tons/y), with household expenditures corresponding
to € 0.16 billion in 2010. Despite these high figures,
the economic importance of high-mercury species is
lower than the benefits calculated in the present
study, thus emphasizing the need for abatement.
More extensive human biomonitoring would allow a
more precise measurement of exposure and would help
elaborate recommendations and information to reduce
environmental exposures to MeHg [50]. Such studies
need to be extended to all of the EU and beyond. How-
ever, information alone would not suffice to change diet-
ary habits and taxes and subsidies would be necessary to
encourage consumption changes [51]. Our results sug-
gest that the benefits of exposure control justify such
actions.
Conclusions
Annual benefits of removing Hg exposure can be esti-
mated in the order between € 1 billion and € 9 billion in
France. While our results support enhanced public pol-
icies for the prevention of MeHg exposure, the eco-
nomic estimates are highly influenced by uncertainties
regarding the dose–response relationship. Benefits might
be underestimated because costs linked to all aspects of
neurotoxicity and to cardiovascular diseases have not
been considered. The data from France support the no-
tion that precautionary measures are called for to
minimize exposure to this hazardous pollutant.
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